Categories: DevelopmentDrug
Get full access to this domain. Easy, seamless transactions. Zero percent financing available.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.07.2010 | - | $21M | - |
Mentions in press and media 2
| Date | Title | Description |
| 19.07.2010 | Kidney disease drug developer Sorbent Therapeutics raises $21M | “There’s no drug that removes clinically significant amounts of sodium and fluid on the market,” he said.
The trial is expected to wrap up early next year. Sorbent hopes to prove that the drug removes sodium from patients’ bodies and reduce... |
| - | Kidney disease drug developer Sorbent Therapeutics raises $21M | Sorbent Therapeutics Inc. has raised a $21 million Series B round to fund Phase 2 clinical trials of a non-absorbed polymer-based drug for end-stage renal disease.
The company’s renal disease drug, called CLP 1001, isn’t absorbed into the b... |
Reviews 0
